A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine

NCT06088745 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Vaccine-Preventable Diseases
Herpes Zoster

Interventions

BIOLOGICAL: Recombinant Herpes Zoster Vaccine
BIOLOGICAL: Recombinant Herpes Zoster Vaccine Placebo

Sponsor

Beijing Luzhu Biotechnology Co., Ltd.